News

Soleno signals $500M cash war chest and robust Vykat XR launch trajectory while advancing EU expansion

Discover key insights from Soleno Therapeutics' Q2 2025 earnings call, highlighting Vykat XR's strong launch, revenue growth, EU expansion efforts & ...